Oncology-Based Molecular Diagnostics Market By Product Type (Kits & Reagents, Instruments & Platforms, Companion Diagnostics (CDx), Laboratory Developed Tests (LDTs), Consumables, Software & Bioinformatics Tools), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Hematologic Malignancies, Melanoma, Others), By Sample Type (Tissue Biopsy, Liquid Biopsy, Urine, Buccal Swab, Cerebrospinal Fluid (CSF), Bone Marrow Aspirate), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Chromogenic In Situ Hybridization, Microarrays, Methylation & Epigenetic Assays, Immunoassays, Spatial Transcriptomics), By Test Purpose (Early Detection, Molecular Characterization, Prognostic Testing, Companion Diagnostics, Therapy Monitoring, Minimal Residual Disease (MRD) & Recurrence Monitoring, Pharmacogenomics, Others), By End User (Hospitals & Oncology Centers, Central Laboratories, Academic & Research Institutes, Clinical Research Organizations (CROs) & Pharma Companies, Community Clinics, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035.

Published Date: Sep 2025 | Report ID: MI3562 | 220 Pages


Report Coverage:

By Product Type

  • Kits & Reagents
  • Instruments & Platforms
  • Companion Diagnostics (CDx)
  • Laboratory Developed Tests (LDTs)
  • Consumables
  • Software & Bioinformatics Tools

By Cancer Type

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Hematologic Malignancies
  • Melanoma
  • Others

By Sample Type

  • Tissue Biopsy
  • Liquid Biopsy
  • Urine
  • Buccal Swab
  • Cerebrospinal Fluid (CSF)
  • Bone Marrow Aspirate

By Technology

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Chromogenic In Situ Hybridization
  • Microarrays
  • Methylation & Epigenetic Assays
  • Immunoassays
  • Spatial Transcriptomics

By Test Purpose

  • Early Detection
  • Molecular Characterization
  • Prognostic Testing
  • Companion Diagnostics
  • Therapy Monitoring
  • Minimal Residual Disease (MRD) & Recurrence Monitoring
  • Pharmacogenomics
  • Others

By End User

  • Hospitals & Oncology Centers
  • Central Laboratories
  • Academic & Research Institutes
  • Clinical Research Organizations (CROs) & Pharma Companies
  • Community Clinics
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Illumina, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • PerkinElmer, Inc.
  • Guardant Health, Inc.
  • Exact Sciences Corporation

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.